Literature DB >> 32658016

Why Make the Cut? Trochanteric Slide Osteotomy Can Improve Exposure to the Anterosuperior Acetabulum.

Kevin D Phelps1, Colin V Crickard2, Katherine Li1, Luke S Harmer1, Erica Andrews McArthur1, Katherine Sample Robinson1, Stephen H Sims1, Joseph R Hsu1.   

Abstract

OBJECTIVE: To define relative increases in visual bony surface area and access to critical landmarks with the addition of a trochanteric slide osteotomy to a Kocher-Langenbeck approach.
METHODS: A Kocher-Langenbeck approach followed by a trochanteric slide osteotomy was sequentially performed on 10, fresh-frozen, hemipelvectomy cadaveric specimens. Visual and palpable access to relevant surgical landmarks was recorded. Calibrated digital photographs were taken of each approach and analyzed using Image J.
RESULTS: The acetabular surface area exposed was 27.66 (±6.67) cm2 for a Kocher-Langenbeck approach. This increased to and 41.82 (±7.97) cm2 with the addition of a trochanteric osteotomy. The exposed surface area was increased by 51.2% for the trochanteric osteotomy (P < 0.001). The superior margin of the acetabulum could be visualized and palpably accessed in both exposures. Access to the more anterosuperior portions of the acetabulum was consistently possible in the trochanteric osteotomy but not with the Kocher-Langenbeck approach.
CONCLUSIONS: A trochanteric osteotomy may visually improve access to the most anterosuperior acetabulum but does not significantly improve surgical access to relevant portions of the superior acetabulum when compared with a Kocher-Langenbeck approach.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Mesh:

Year:  2021        PMID: 32658016     DOI: 10.1097/BOT.0000000000001900

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  1 in total

1.  Midterm results of digastric trochanteric flip osteotomy for high acetabular posterior wall fracture.

Authors:  Yuneng Li; Yufeng Ge; Haonan Liu; Shiwen Zhu; Xinbao Wu
Journal:  Int Orthop       Date:  2022-05-25       Impact factor: 3.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.